Citadel Advisors »

Aikido Pharma shares owned by Citadel Advisors

Quarter-by-quarter ownership of Aikido Pharma (DOMH) shares owned by Citadel Advisors from 13F filings

Historical chart of Citadel Advisors investment in Aikido Pharma

Tip: Access up to 7 years of quarterly data

All positions including Aikido Pharma held by Citadel Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aikido Pharma by Citadel Advisors

Quarter filed Position value Share count Share price at filing
2025-09-30 $1.5M 205k 7.09
2024-12-31 $17k 17k 1.00
2023-06-30 $52k 18k 2.91

More positions owned by Citadel Advisors

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Tesla Motors Call Option (TSLA)
NVIDIA Corporation Call Option (NVDA)
Apple Call Option (AAPL)
Meta Platforms Cl A Call Option (META)
Microsoft Corporation Call Option (MSFT)
Spdr Gold Tr Gold Shs Call Option (GLD)
Ishares Tr Russell 2000 Etf (IWM)
Amazon Call Option (AMZN)
Strategy Cl A New Call Option (MSTR)
Alphabet Cap Stk Cl A Call Option (GOOGL)
UnitedHealth Call Option (UNH)
Palantir Technologies Cl A Call Option (PLTR)
Netflix Call Option (NFLX)

View all positions for Citadel Advisors

Top funds holding Aikido Pharma

Vanguard Group
Connective Capital Management
Jane Street
Citadel Advisors
BlackRock
Two Sigma Investments
Geode Capital Management
State Street Corporation
Two Sigma Advisers
Millennium Management
Magnus Financial Group
Hrt Financial
Dimensional Fund Advisors
KKM Financial
Northern Trust

View all funds holding Aikido Pharma